ABATTIS BIOCEUTICALS

abattis-bioceuticals-logo

Abattis Bioceuticals Corporation is a specialty bio-technology life sciences company that has acquired intellectual property, conducts research, and works to develop proprietary health and wellness solutions that address chronic illnesses and disease in animals and humans through proprietary and patent pending formulations. The Company has identified targeted channels to market and license proprietary patent pending products throughout the world. http://www.abattis.com/s/news.asp?ReportID=692690 SEDAR Filings: http://www.sedar.com/DisplayProfile.do?lang=EN&issuerType=03&issuerNo=00011477

#SimilarOrganizations #People #Financial #Website #More

ABATTIS BIOCEUTICALS

Social Links:

Industry:
Biotechnology Health Care Medical

Founded:
1997-09-29

Address:
Vancouver, British Columbia, Canada

Country:
Canada

Website Url:
http://www.abattis.com

Total Employee:
11+

Status:
Active

Contact:
(604) 538-6650

Email Addresses:
[email protected]

Total Funding:
400.99 K USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Euro Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS


Similar Organizations

cel-sci-logo

CEL-SCI

CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.

foundation-medicine-logo

Foundation Medicine

Foundation medicine is a molecular information company developing clinical diagnostic tests that facilitates personalized cancer therapies.

illumina-logo

Illumina

Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.


Current Advisors List

dr-michelle-sexton_image

Dr. Michelle Sexton Founder/Chief Science Officer of Phytalab - PhytaLab is owned 51% by Abattis through its subsidiary @ Abattis Bioceuticals
Board_member

mike-withrow_image

Mike Withrow President & CEO @ Abattis Bioceuticals
Board_member

Current Employees Featured

not_available_image

Jason Anderson
Jason Anderson CA, CFA as Vice President of Finance @ Abattis Bioceuticals
CA, CFA as Vice President of Finance
2014-08-08

michael-bessler_image

Michael Bessler
Michael Bessler Corporate Communications Consultant @ Abattis Bioceuticals
Corporate Communications Consultant
2015-02-04

dr-michelle-sexton_image

Dr. Michelle Sexton
Dr. Michelle Sexton Chief Science Officer of PhytaLab - PhytaLab is owned 51 percent by Abattis through its subsidiary. @ Abattis Bioceuticals
Chief Science Officer of PhytaLab - PhytaLab is owned 51 percent by Abattis through its subsidiary.

douglas-sorocco_image

Douglas Sorocco
Douglas Sorocco LLb, Director @ Abattis Bioceuticals
LLb, Director

guy-dancosse_image

Guy Dancosse
Guy Dancosse Director @ Abattis Bioceuticals
Director

william-bill-fleming_image

William "Bill" Fleming
William "Bill" Fleming CEO @ Abattis Bioceuticals
CEO

jaouad-fichtali_image

Jaouad Fichtali
Jaouad Fichtali Chief Technology Officer @ Abattis Bioceuticals
Chief Technology Officer
2014-11-17

dr-tim-fealey_image

Dr. Tim Fealey
Dr. Tim Fealey PhD, Director @ Abattis Bioceuticals
PhD, Director

brazos-minshew_image

Brazos Minshew
Brazos Minshew President Of Biocell Labs @ Abattis Bioceuticals
President Of Biocell Labs
2014-07-01

emanuel-manny-montenegrino_image

Emanuel "Manny" Montenegrino
Emanuel "Manny" Montenegrino Director @ Abattis Bioceuticals
Director

Founder


mike-withrow_image

Mike Withrow

Stock Details


Company's stock symbol is CNSX:ATT

Acquisitions List

Date Company Article Price
2019-04-02 Pro Natura BV Pro Natura BV acquired by Abattis Bioceuticals 6.68 M EUR
2016-10-24 Experion Bio Technologies Inc. Experion Bio Technologies Inc. acquired by Abattis Bioceuticals 7.5 M USD

Official Site Inspections

http://www.abattis.com

  • Host name: 104.21.4.100
  • IP address: 104.21.4.100
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Abattis Bioceuticals"

Abattis Bioceuticals - Crunchbase Company Profile & Funding

Abattis Bioceuticals Corporation is a specialty bio-technology life sciences company that has acquired intellectual property, conducts research, and works to develop proprietary health and โ€ฆSee details»

Abattis Bioceuticals Corp. - Canadian Securities Exchange

Dec 23, 2010 Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTCQB: ATTBF) (CSE: ATT), specialty biotechnology company with capabilities through its wholly-owned subsidiaries โ€ฆSee details»

Abattis Bioceuticals Corp. (ATTBF) - Yahoo Finance

See the company profile for Abattis Bioceuticals Corp. (ATTBF) including business summary, industry/sector information, number of employees, business summary, corporate governance, โ€ฆSee details»

Abattis Bioceuticals Corp (CSE: ATT) - LinkedIn

Abattis Bioceuticals is a life sciences company that aggregates and invests in biotechnology services internationally. | OUR STORY Abattis is publicly traded speciality agricultural โ€ฆSee details»

Abattis Bioceuticals Corp. (ATTBF) - Yahoo Finance Canada

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and โ€ฆSee details»

Abattis Bioceuticals Company Profile 2024: Valuation, Funding ...

Abattis Bioceuticals General Information Description. Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in โ€ฆSee details»

ATTBF | Abattis Bioceuticals Corp. Profile | MarketWatch

Abattis Bioceuticals Corp. It produces, markets, and licenses proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic, and animal nutrition markets.See details»

Abattis and Management Overcome Legal and Regulatory

Mar 19, 2021 After Over Two Years of Legal and Regulatory Battles, Abattis & its Management Receive Vindication VANCOUVER, British Columbia, March 19, 2021 ...See details»

Abattis Bioceuticals - Contacts, Employees, Board Members, โ€ฆ

Abattis Bioceuticals has 10 current employee profiles, including CA, CFA as Vice President of Finance Jason Anderson. Abattis Bioceuticals has 2 board members and advisors, including โ€ฆSee details»

Abattis Bioceuticals Narrowly Avoids Delisting from Canadian โ€ฆ

Aug 9, 2019 Abattis appears to have avoided the delisting event thanks to finally filing its audited financial statements late last night. The firm reported sales of $8,371 for the year ended โ€ฆSee details»

Abattis and Management Overcome Legal and Regulatory โ€ฆ

Mar 19, 2021 After Over Two Years of Legal and Regulatory Battles, Abattis & its Management Receive Vindication. VANCOUVER, British Columbia, March 19, 2021 (GLOBE NEWSWIRE) โ€ฆSee details»

Abattis Announces Acquisition of European Nutraceutical โ€ฆ

Abattis' products and services divisions include its Abattis-branded vaporizer line, as well as the proprietary cannabinoid therapeutic, COMFORTโ„ข, formulated to treat chronic pain and โ€ฆSee details»

Abattis Bioceuticals (ATT) Stock Price, News & Analysis - MarketBeat

5 days ago Abattis Bioceuticals Corp. is a specialty biotechnology company. The Company aggregates, incubates, integrates and invests in the natural health product and botanical drug โ€ฆSee details»

Abbatis Bioceuticals Corp. Announces Launch Of Redesigned โ€ฆ

Jun 17, 2014 Abattis Bioceuticals Corp. (OTCPINK: ATTBF) saw its share volume remain strong on June 17th with 1,316,503 shares exchanging hands, slightly higher than its three month โ€ฆSee details»

Abattis Announces Acquisition of European Nutraceutical

Apr 2, 2019 The Acquisition Subsidiary has also agreed to pay Catalyst (i) a โ‚ฌ5,000,000 milestone payment within two years of Abattis CBD products being launched through Pro โ€ฆSee details»

ATTBF Stock Price Quote | Morningstar

Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services โ€ฆSee details»

Abattis and Management Overcome Legal and Regulatory โ€ฆ

Mar 19, 2021 Abattis was named in Order and the Notice of Hearing, but the Companyโ€™s officers and directors were not. On January 16, 2019, the BCSC Panel revised the Order and Abattis โ€ฆSee details»

Abattis and Management Overcome Legal and Regulatory โ€ฆ

Mar 19, 2021 Abattis was named in Order and the Notice of Hearing, but the Companyโ€™s officers and directors were not. On January 16, 2019, the BCSC Panel revised the Order and Abattis โ€ฆSee details»

Abattis Bioceuticals Corp (ATTBF) Stock Price and News

Aug 24, 2010 Real-time Price Updates for Abattis Bioceuticals Corp (ATTBF), along with buy or sell indicators, analysis, charts, historical performance, news and moreSee details»

Abattis Bioceuticals to Dispose of Cannabis Operations

Nov 9, 2019 Abattis will now begin the process of disposing of its cannabis-related operations over the coming months. The issuer currently owns Gabriola Green Farms, a โ€œlate stageโ€ โ€ฆSee details»

linkstock.net © 2022. All rights reserved